GLORIA PHARMA: Puxing Puli plans to transfer 20.64% equity of GLORIA PHARMA to repay the debts owed by Puxing Puli to the company
I'm PortAI, I can summarize articles.
GLORIA PHARMA announced that it will resolve the debt dispute regarding the equity transfer payment with Pusheng Puli through an agreement. Pusheng Puli intends to transfer its 20.64% equity stake in GLORIA PHARMA to Youpeng Bio, and the proceeds will be used to repay debts owed to the company. The lawsuit regarding this equity transfer has entered the enforcement stage, and the subsequent process is complex and uncertain
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments